Search PubMedSearch

Biomedical subjects

S Afonso

Publications and source records attributed to S Afonso.

At least 19 recordsLinked to original sources

The effect of griseofulvin on the heme pathway. Studies on tissue explant cultures.

The effect of griseofulvin on porphyrin biosynthesis was studied in vitro and in vivo using liver and skin explants from mice. Neither porphyrin nor precursors accumulation was detected after in vitro treatment of explants with griseofulvin. Culture medium porphyrins formed from added delta-amino-laevulinic acid (ALA) were increased after oral chronic intoxication. Similar results were obtained by cutaneous and oral intoxication. Consequently griseofulvin topical application is proposed as an alternative method to produce experimental erythropoietic protoporphyria. Probable intoxication mechanisms are proposed to explain the porphyrinogenic action of griseofulvin.

Animals

The acute systemic and coronary hemodynamic effects of acetaldehyde.

Acute coronary and systemic hemodynamic effects of acetaldehyde before and subsequent to beta adrenergic blockade by propranolol were studied in intact anesthetized dogs. Acetaldehyde produces a sympathomimetic effect compatible with catecholamine release as seen by an increase in heart rate, cardiac output, pulmonary and systemic pressures and body oxygen consumption. The marked decrease in coronary vascular resistance and increase in coronary blood flow is blocked to only a minor degree by propranolol, indicating that a major part of its action on the coronary circulation is not due to catecholamine release. Acetaldehyde dilates large coronary vessels and appears to increase collateral blood flow to obstructed arteries, as determined by angiographic study.

Acetaldehyde

The systemic and coronary hemodynamic effects of intracoronary arterial tolazoline (Priscoline).

Intracoronary injection of tolazoline in dogs produces transient coronary vasodilatation with marked reduction in the arteriovenous oxygen difference and little change in myocardial oxygen consumption. At lower doses coronary effects are produced almost exclusively but as the dose increases, systemic cardiovascular changes occur also. No fatalities occurred even with large doses of tolazoline into the coronary arteries of these healthy dogs. Since intraarterial tolazoline is used to improve visualization of vascular beds in other portions of the body, its possible use for coronary arteriography is discussed.

Animals

Systemic and coronary haemodynamic effects of ketamine in intact anaesthetized and unanaesthetized dogs.

Ten intact anaesthetized dogs breathing room air spontaneously (Group A) were compared with ten artificially ventilated dogs (Group B). All were given a bolus of ketamine 2 mg/kg followed by a 20-min infusion of ketamine 0.1 mg/kg/min. In Group A, coronary sinus blood flow, measured with a thermodilution flowmeter, increased by 90% while coronary vascular resistance decreased by 28% and coronary sinus oxygen content decreased by 27%. Heart rate increased by 47%, and arterial pressure by 9%. Cardiac output, calculated by the dye dilution method, increased by 29%, while the left ventricular work index decreased by 50%. Minute ventilation rate decreased by 55%. The Group B dogs were studied as described above, except that they were artificially ventilated. The haemodynamic ahanges were less in Group B, possibly because of improved arterial oxygenation. Heart rate increased by 24%, cardiac output by 21% and arterial pressure by 2%. The coronary sinus blood flow increased by 12% while coronary vascular resistance decreased by 11%. Coronary sinus oxygen concentration decreased by 15%. Five unanaesthetized dogs with electromagnetic flowmeter probes chronically implanted on the aorta and circumflex coronary artery, and an indwelling arterial catheter were studied before, during and after the intravenous administration of ketamine 2, 4, and 8 mg/kg. A dose of 8 mg/kg produced increases in cardiac output, heart rate and arterial pressure of 21%, 44% and 24%, respectively, while coronary blood flow increased 47%. We conclude that, in healthy dogs, ketamine produces an increase in heart rate and cardiac work. A significant increase in coronary blood flow appears to be insufficient to meet the metabolic demands of the myocardium, as the coronary sinus oxygen content decreased.

Anesthesia, General

Indomethacin and the prostaglandin hypothesis of coronary blood flow regulation.

1. Recent experimental data support the view that prostaglandins might be involved in autoregulation of coronary blood flow. Since indomethacin blocks prostaglandin synthesis, the present study was performed to determine whether indomethacin also inhibits coronary vasodilatation induced by hypoxia.2. Coronary and systemic haemodynamic and metabolic effects of hypoxia (5% and 8% oxygen in nitrogen) were studied in intact, anaesthetized and vagotomized dogs before and after indomethacin.3. 30 and 60 min after administration of indomethacin coronary blood flow increases produced by hypoxia were considerably lower than those before indomethacin.4. These results are held to lend support to the hypothesis that prostaglandins are involved in the autoregulation of coronary blood flow.

Animals

Coronary vasodilator responses to hypoxia before and after aminophylline.

1. In previous studies adenosine has been postulated to be the mediator in coronary blood flow regulation and aminophylline was found to inhibit the coronary vasodilator action of adenosine. The present study was performed to determine whether aminophylline inhibits coronary vasodilatation induced by hypoxia.2. Coronary and systemic haemodynamic and metabolic effects of hypoxia were studied in anaesthetized dogs before and after aminophylline. Aminophylline did not influence coronary vasodilatation induced by hypoxia.3. These results are held not to lend support to the hypothesis that adenosine is the metabolite responsible for the regulation of coronary blood flow.

Adenosine